Management Name : Miss SUJITRA SAENGDUEANCHAI | Type of securities : Common share | Methods of Acquisition / Disposition : Buy | Transaction Date : 21/06/2018
Management Name : Miss SUJITRA SAENGDUEANCHAI | Type of securities : Common share | Methods of Acquisition / Disposition : Sell | Transaction Date : 22/06/2018
Management Name : Miss SUJITRA SAENGDUEANCHAI | Type of securities : Common share | Methods of Acquisition / Disposition : Sell | Transaction Date : 25/06/2018
Of Details DOD BIOTECH PUBLIC COMPANY LIMITED 2021 Company Year 31/12/2021 DOD BIOTECH PUBLIC COMPANY LIMITED 2021 Consolidated Year 31/12/2021 DOD BIOTECH PUBLIC COMPANY LIMITED 2021 Reviewed
Their Finances More Resilient to the Ever-changing Context?” with a view to emphasizing the importance of money management knowledge and skills to cope with the unexpected in life. Key messages to be
reports in the case of any unexpected event, and the submission period will be based on business days instead of calendar days to allow business operators to have more time.SEC has made the public
- Translation- June 11, 2019 Subject: Notification the Acquisition of share of BS Myco Biotech Company Limited. (Additional Information Memorandum Concerning the Acquisition of Assets) To: Director and Manager
DOD BIOTECH PUBLIC COMPANY LIMITED เลขที ่111 หมู่ที ่2 ต ำบลท่ำจีน อ ำเภอเมืองสมุทรสำคร จังหวดัสมุทรสำคร 74000 111 Moo 2 TambonThachin, Amphurmuangsamutsakhon, Samutsakhon 74000 No. DOD089/2563
with unexpected problems that occurred in the production process during 2019. Consequently, the production cost per unit has increased Selling Expenses Selling expenses for the fiscal year 2019 were in
unexpected pandemic of COVID-19, resulted to unavoidable significant impact to revenue and operating result of the Company. However, the Executive and their team has brainstormed and made a strategic planning